The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 26, 2023

Filed:

Feb. 21, 2020
Applicant:

Edwards Lifesciences Cardiaq Llc, Irvine, CA (US);

Inventors:

Richard George Cartledge, Boca Raton, FL (US);

John P. Cartledge, Boca Raton, FL (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/06 (2013.01); A61F 2/07 (2013.01); A61F 2/954 (2013.01); A61F 2/90 (2013.01); A61F 2/89 (2013.01); A61F 2/95 (2013.01); A61B 17/115 (2006.01); A61B 17/072 (2006.01); A61F 2/958 (2013.01); A61F 2/966 (2013.01); A61F 2/848 (2013.01);
U.S. Cl.
CPC ...
A61F 2/07 (2013.01); A61B 17/07207 (2013.01); A61B 17/115 (2013.01); A61F 2/06 (2013.01); A61F 2/848 (2013.01); A61F 2/89 (2013.01); A61F 2/954 (2013.01); A61F 2/958 (2013.01); A61F 2/966 (2013.01); A61B 17/1155 (2013.01); A61B 2017/07228 (2013.01); A61B 2017/1157 (2013.01); A61F 2/90 (2013.01); A61F 2002/061 (2013.01); A61F 2002/077 (2013.01); A61F 2002/8483 (2013.01); A61F 2002/8486 (2013.01); A61F 2002/9534 (2013.01); A61F 2220/0016 (2013.01); A61F 2250/001 (2013.01);
Abstract

A vascular system includes a delivery apparatus and an endovascular device. The delivery apparatus including a catheter and a control lead. The control lead extends through a lumen of the catheter and is configured to be manipulated by a user. The endovascular device is releasably coupled to the delivery apparatus and includes an implant body, a seal extending radially outwardly from the implant body, and one or more tissue engaging elements. The seal is configured to contact native vascular tissue to reduce leakage between the native vascular tissue and the implant body. The tissue engaging elements are pivotable relative to the seal from a compressed state to an expanded state. In the compressed state, the tissue engaging elements are positioned so as to disengage the native vascular tissue. In the expanded state, the tissue engaging elements extend outwardly from the seal and are configured to engage the native vascular tissue.


Find Patent Forward Citations

Loading…